Genprex, Inc. (GNPX)

Genprex, Inc. (GNPX)

$1.06 USD

0.04 (-3.61%)

Updated Jul 16 6:55pm

Add GNPX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

GNPX Daily Price Range
GNPX 52-Week Price Range

GNPX News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All GNPX News

Genprex, Inc. (GNPX) Company Bio

Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.

GNPX Stock Chart More Charts

GNPX Price/Volume Stats

Current price $1.06
Prev. close $1.10
Day low $1.05
Day high $1.12
50-day MA $1.45
200-day MA $1.55
52-week high $7.88
52-week low $0.95
Volume 26,200
Avg. volume 38,556
Dividend yield N/A
Market Cap 16.54M

GNPX Social Stream

Loading social stream, please wait...

View Full GNPX Social Stream

GNPX Returns

1-mo -24.82%
3-mo -39.77%
6-mo -29.33%
1-year -85.83%
3-year N/A
5-year N/A
YTD -3.64%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Page generated in 0.3556 seconds.